The Gross Margin of Aspira Pathlab & Diagnostics Ltd (540788.BO) is 80.14%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 80.14% |
| 2023-03-31 | 82.73% |
| 2022-03-31 | 83.94% |
| 2021-03-31 | 82.68% |
| 2020-03-31 | 76.38% |
| 2019-03-31 | 70.46% |
| 2018-03-31 | 60.40% |
| 2017-03-31 | 81.26% |